International award backs rare disease research

Research exploring new treatment approaches for cystinosis has secured funding for Alan Davidson, a professor of molecular medicine and pathology at Waipapa Taumata Rau, University of Auckland.

A partnership between Health Research Charities Ireland and Ireland's Health Research Board, Davidson's work is one of 12 projects funded through the Joint Funding Scheme, financing internationally competitive and innovative health research. The University of Auckland is the host institution for the project.

Cystinosis is a rare inherited condition in which the amino acid cystine builds up within cells. Over time, the accumulation can damage the kidneys, eyes and other organs, requiring lifelong treatment and specialist care.

Davidson's project, ‘Targeting IL-6 in cystinosis’, is funded in partnership with Cystinosis Ireland. The study will investigate a potential new treatment pathway for the condition.

The work is part of a €3.1 million funding round supporting research into rare diseases, cancer, neurological conditions and healthcare improvement. The latest awards include projects hosted by institutions in Ireland and overseas.

The HRCI-HRB Joint Funding Scheme enables Irish charities to support research in Ireland and abroad and access expertise wherever it is based.

Since its establishment in 2006, the programme has supported 177 research projects, representing a total investment of more than €31 million. Patients and health charities play a central role in funding decisions.